Background: Gestational ethanol (EtOH) exposure is associated with multiple developmental abnormalities, collectively termed fetal alcohol spectrum disorder (FASD). While the majority of women abstain from EtOH following knowledge of pregnancy, one contributing factor to the high FASD prevalence is that pregnancy is not detected until 4 to 6 weeks. Thus, EtOH consumption continues during the initial stages of fetal development.
F ETAL ALCOHOL SPECTRUM disorder (FASD) is a prevalent neurodevelopmental disorder, affecting as many as 2 to 5% of school-aged children in the United States (Lange et al., 2017; May et al., 2009) . A potential contribution to the high prevalence of FASD may be from women that consume alcohol prior to knowing that they are pregnant, when they would otherwise choose not to drink alcohol during pregnancy. Epidemiological data from the United States and Canada show that approximately half of reproductive-age women drink alcohol, and because the precise timing of the beginning of pregnancy is usually not known, a similar proportion drink during the first 5 to 6 weeks of pregnancy, prior to pregnancy awareness (Kesmodel, 2001; Strandberg-Larsen et al., 2008; Tough et al., 2006) . This early exposure might interfere with the initiation of fetal neurogenesis (Stiles and Jernigan, 2010) .
FASD is an umbrella term for the collection of fetal alcohol-induced effects that include physical abnormalities as well as neurocognitive and/or behavioral impairments (Hoyme et al., 2016) such as deficits in executive function, sustained attention tasks, and learning and memory (Hamilton et al., 2003; Kodituwakku, 2009; Manji et al., 2009) . These symptoms are not detectable until several years after birth, and as a result, deficits arising from FASD are difficult to identify at early ages. Nevertheless, early detection is critical, because the risk for adverse long-term life outcomes associated with FASD is significantly diminished for individuals identified early in life (Streissguth et al., 2004) . Therefore, it would be ideal to detect the effects of earlygestation alcohol exposure on the developing brain during pregnancy. Recent advances in fetal magnetic resonance imaging (MRI) have enabled noninvasive, quantitative study of fetal brain growth throughout the second half of gestation Scott et al., 2011) . One advanced MRI method, termed diffusion MRI, has demonstrated the potential for detecting abnormal morphological development of neurons in the developing cerebral cortex of rodents (Leigland et al., 2013a) . In order to test the capability of fetal MRI to detect the effects of ethanol (EtOH) exposure on the developing brain in the second half of gestation, an animal model that is similar in gestational length to humans is required. Herein, we describe a nonhuman primate (NHP) model that has been designed to develop a noninvasive method for identifying neuroanatomical developmental abnormalities that arise from early-life alcohol exposure.
The use of NHPs, particularly rhesus macaques, has several advantages for generating results with high translatability to human clinical contexts. First, the length of gestation, relative to central nervous system development, exhibits higher similarity to humans than other animal model systems such as rodents (Workman et al., 2013) . Throughout the second half of gestation, rhesus macaque brains undergo similar phases of brain growth to humans at the same gestational stage. This is a period in which the surface area of the cerebral cortex increases rapidly, the cortex folds, and myelination of many white matter fiber systems is initiated, exhibiting close similarity to human gestational timing relative to brain development. Therefore, macaque monkeys are ideal for assessing the potential of in utero MRI in the detection of brain developmental abnormalities associated with fetal exposure to EtOH. Second, rhesus macaques drink EtOH in a similar manner to humans. Specifically, when given open access, a large proportion voluntarily drink EtOH in amounts similar to the chronic drinking levels exhibited by human alcoholics (Baker et al., , 2017 Mello and Mendelson, 1972) . The rate of EtOH absorption and clearance are also more similar between humans and macaques than rodents (Green et al., 1999; Vivian et al., 2001) . To date, the majority of NHP fetal alcohol exposure studies have administered alcohol via intragastric gavage (Clarren and Astley, 1992; Clarren and Bowden, 1982; Scott and Fradkin, 1984; VandeVoort et al., 2015) . The remaining studies report administration via a permanently implanted intragastric cannula (Altshuler and Shippenberg, 1981) , intravenous delivery , or self-administration (Elton and Wilson, 1977; Schneider et al., 2001) . The rhesus macaque model described here leverages the ability to induce oral intake of a controlled amount of EtOH (Grant et al., 2008; Vivian et al., 2001 ) with the highly relevant gestational and neurodevelopmental profiles in combination with multidisciplinary and longitudinal techniques that are already available in routine prenatal care settings. We demonstrate the ability to induce drinking of 1.5 g/kg/d of EtOH (an approximate human equivalent of 6 drinks/d) beginning prior to pregnancy and extending through the first 60 days of the 168-day gestational term of macaques. This model employs minimal use of anesthetics by training animals to comply with awake venipuncture and ultrasound, which can potentially confound studies of EtOH exposure in utero (Brambrink et al., 2010 (Brambrink et al., , 2012 . This report examined the rate of drinking the 1.5 g/kg dose and the subsequent blood EtOH concentrations (BECs), the effect of EtOH on generating pregnancies, and the effect of pregnancy on drinking behavior. The data presented here will therefore serve as a reference for future publications and studies supported by tissue and data available through the Monkey Alcohol Tissue Research Resource (MATRR, http://www.matrr.com). Ultimately, this animal model is designed to assess whether fetal MRI possesses the requisite sensitivity to detect neurodevelopmental abnormalities in the second half of gestation, and if so, at which gestational age the highest degree of sensitivity to EtOH-induced damage is achieved. The feasibility of in utero fetal MRI, followed by ex vivo electrophysiological and MRI studies to validate the functional significance of potential anatomical findings, is also demonstrated herein. Future reports will focus on the effects of fetal alcohol exposure on anatomical and functional brain development in the context of this model.
MATERIALS AND METHODS

Subjects
Forty-two multiparous female rhesus macaques were enrolled in this study. All procedures were conducted in accordance with the Guide for the Care and Use of Laboratory Animals and the National Institutes of Health Guidelines for the Care and Use of Laboratory Animal resources and approved by the Oregon National Primate Research Center (ONPRC) Institutional Animal Care and Use Committee.
Dams were individually housed in 76 9 60 9 60-cm stainless steel cages, with visual and auditory contact with conspecifics, except during breeding (see below). These subjects were maintained on a positive caloric diet of 1-g banana pellets (TestDiet, St. Louis, MO, and Bio-Serv Flemington, NJ) and housed in a temperature (21 AE 1°C) and humidity (30 to 50%)-controlled environment with a 11:13-hour light/dark cycle. A cross-sectional, rather than longitudinal design was employed for this study to avoid varying amounts of isoflurane and ketamine throughout pregnancy. Of the 42 recruited animals, 31 exhibited both consistent menstrual cycles conducive for scheduling time-mated breeding and reliable consumption of 1.5 g/kg/d EtOH or a caloric equivalent of maltose dextrin solution, and hence were chosen to undergo time-mated breeding procedures. Animals that were not pregnant after 5 breeding attempts were removed from the study. This resulted in exclusion of 6 of the remaining 31 dams. Of these 6 animals, 5 were EtOH-drinking animals and 1 was a control. In addition, 4 of the dams initially assigned as control animals were reenlisted in the EtOH group following their first caesarean section (remaining within the same gestational cohort). These 4 dams generated 3 additional EtOH-exposed fetuses (one did not become pregnant after 5 breeding attempts). Data regarding the age, weight, and number of prior pregnancies of 25 assigned dams that produced the 28 fetuses are detailed in Table 1 , according to each animal's MATRR ID number. One control fetus was found to be a naturally occurring case of intrauterine growth restriction (IUGR) due to placental insufficiency (Lo et al., 2018) , and in one of the EtOH cases, drinking was unintentionally allowed to continue until the 108th day of gestation (as described in "Pregnancy Confirmation," below). The 28 pregnancies were assigned as follows: G85 (n = 4 drinkers, n = 4 controls), G110 (n = 5 drinkers, n = 5 controls), and G135 (n = 5 drinkers, n = 5 controls). Specific information related to each fetus is summarized in Table 2 , according to its MATRR ID number.
Blood Collection
Each dam was trained to participate in awake blood collection as previously described (Jimenez et al., 2015) . Briefly, animals were reinforced with food (fresh fruit, vegetables, or nuts) for coming to the front of the cage and presenting their leg through a 10 9 10 cm opening. Blood (3 ml) was collected from the femoral vein in BD Vacutainer tubes (Fisher Scientific, Waltham, MA) through a 22-gauge needle. This procedure routinely demonstrates low levels of circulating stress hormones (Jimenez et al., 2015 (Jimenez et al., , 2017 . For progesterone (P4) and estradiol (E2) measurements, blood was collected 1 to 3 times each week within the first 3 hours of the light cycle and stored on ice for approximately 30 minutes until centrifuged for 15 minutes at 4°C (Model Allegra 21R benchtop centrifuge; Beckman Colter, Atlanta, GA). Plasma aliquots were stored at À80°C until assayed for P4 and E2 by the ONPRC Endocrine Technology Services Laboratory using a Cobas e411 Analyzer (Roche, Clifton, NH) with 0.03 to 60 ng/ml and 5 to 4,300 pg/ml sensitivity, respectively.
For BEC measurements, blood was collected from the saphenous vein of EtOH-drinking animals only, every 3 to 7 days, 90 minutes after the daily drinking session began. This time point was chosen based on previous studies showing peak BEC following gavage of 1.5 g/kg EtOH is at 90 minutes (Green et al., 1999) , and is consistent with the EtOH self-administration protocol used here (Grant et al., 2008; Vivian et al., 2001 ). Blood (20 ll) was diluted 25-fold with sterile water, which has been demonstrated to be a sufficient dilution to suppress effects of plasma constituents on EtOH concentration determinations (Tangerman, 1997; Tiscione et al., 2011) , and frozen in a sealed glass vial until assayed. Duplicate standards of known EtOH concentration ranging from 25 to 400 mg/dl were used to generate a standard curve. Standards and samples were assayed on the same day using gas chromatography (Hewlett Packard 5890 Series II; Avondale, PA), equipped with a headspace autosampler, flame ionization detector, and a Hewlett Packard 3392A integrator.
EtOH Availability
Details of the operant panel have been previously described (Grant et al., 2008; Vivian et al., 2001) . Briefly, an operant panel Defined as the weight at time of C-section minus weight at time of conception. c These animals underwent 2 pregnancies within this study as described in the text.
replaced 1 wall of each cage. The operant panels had 2 sets of 3 lights (white, red, and green) that signaled an active session, and food and fluid availability, respectively. Below each light set was a fluid spout (for a total of 2 fluid spouts per panel) that was activated by pulling a recessed dowel located near the center of the panel. Nalgene tubing connected each fluid spout (water and either EtOH or maltose dextrin) to a 1-l fluid reservoir positioned on a digital scale (Ohaus Navigator Balances N1B110; Ohaus Corporation, Pine Brook, NJ). A 1-g banana food pellet was delivered on a fixed time 300-second (FT-300) schedule until the predetermined volume of fluid was consumed, after which time water was freely available. Any remaining pellets were available on a FR-1 schedule after a 2-hour time-out by pulling the recessed dowel and activating an infrared finger-poke. Dowel pulls, finger pokes, and fluid consumption were recorded every 500 ms via a computerized system using custom hardware and programming environment (National Instruments interface and LabVIEW Software; Austin, TX). The first phase of the induction procedure requires each animal to consume a volume of water that is equivalent to the volume of 1.5 g/kg of 4% EtOH (w/v). Next, animals were required to consume increasing volumes of 4% EtOH to achieve daily doses equal to 0.5 and then 1.0 g/kg in approximately 30-day increments. Animals were then maintained on 1.5 g/kg/d until gestational day 60 (G60) (Fig. 1) . Animals assigned to the control group experienced identical conditions, but an isocaloric maltosedextrin solution was available in place of EtOH. To aid in palatability, a 1 to 2% (w/v) peach-flavored powder was added to both EtOH and maltose dextrin solutions. Beginning on G61 EtOH was replaced with a 1.5 g/kg/d volume equivalent of the maltosedextrin/peach juice vehicle and continued until the termination of the pregnancy. Daily sessions were 22 hours. Food and fluids were replenished daily.
Time-Mated Breeding
Each dam was trained to present their perineum for daily vaginal swabbing to monitor the length of each menstrual cycle. The first day of mense defined the start of a new cycle (day 1; Fig. 2A ). Ovulation was estimated as 14 days prior to the end of the average cycle and verified by triweekly P4 and E2 assays. Daily P4/E2 blood samples were obtained and assayed as the dam was suspected to be approaching ovulation. A midcycle rise in E2 (>100 pg/ml) was suggestive of upcoming ovulation ( Fig. 2A , orange bar). At this time, females were transferred to another housing room and pair-housed in a doublewide cage with 1 of the 9 breeding males as part of the ONPRC time-mated breeding program. For dams assigned to the EtOH group, each day the pair was separated for approximately 2 hours, a bottle containing 1.5 g/kg of alcohol was hung on the outside of the female's cage (EtOH group only), and the male was provided a hanging bottle containing 150 g of the maltose dextrin peach-flavored solution. The pair was reunited after the 2-hour window regardless of whether the 1.5 g/kg dose was consumed to allow the pair continuous opportunity to mate. Dams assigned to the control group were not separated from their partner daily. Breeding pairs were maintained until a rapid decline in E2 (<100 pg/ml) was observed, and the dam was returned to her home cage. The first day of pairing was defined as G0.
Pregnancy Confirmation
Circulating P4 and E2 levels were monitored to identify animals likely to be pregnant following pairing (example in Fig. 2B ). If P4 levels remained elevated (>1 ng/ml) following a midluteal phase peak and daily swabs were consistently negative for mense onset, then routine obstetrical ultrasound was performed at approximately Actual gestation age at C-section and necropsy is given, followed by EtOH (E) or control (C) designation.
G50 (range: G47 to G67) to confirm viability. For a subset of these fetuses, biparietal diameter (BPD) measurements were performed (Table 2) . Ultrasounds were performed in the home cage without sedation using a GE LOGIQ eVet portable ultrasound machine (SOUND, Carlsbad, CA) to determine pregnancy viability. If pregnancies were viable, then triweekly E2/P4 measurements were stopped. For animals that were not impregnated, the previously described steps were repeated over subsequent menstrual cycles until a pregnancy was achieved, for a maximum of 5 breeding attempts per dam. For 1 EtOH-drinking animal (Dam 10314), circulating hormone levels were not sufficiently sensitive to detect pregnancy until G108. At this point, this animal's access to EtOH was immediately discontinued; however, this occurred at G108 rather than G60.
In Utero MRI
At the time of pregnancy confirmation, the terminal MRI procedure, caesarean section, and necropsy were scheduled. For several cases, it was not feasible to schedule procedures on the exact gestation day that matched the G85, G110, or G135 age cohort to which the fetus was assigned. In these cases, the nearest available day was scheduled, which was always within 2 days of the planned gestational day (actual gestational ages are listed in Table 2 ). Pregnant females underwent anatomical and diffusion MRI examination of the fetal brain on a 3T Tim Trio (Siemens, Erlangen, Germany) scanner equipped with a 15-element human knee radiofrequency coil. Detailed anesthesia procedures and MRI protocols are described elsewhere (Wang and Kroenke, 2015) .
Caesarean Section and Fetal Brain Collection
Following MRI, the dam was maintained on 1 to 1.5% isoflurane and transported to a surgery suite. For the caesarean section, the dam was placed in dorsal recumbency. The fetus was removed via fundal transverse hysterotomy following umbilical venous and arterial cord blood collection. The umbilical cord was clamped with alligator forceps and transected. The hysterotomy and abdominal incisions were closed in standard fashion, and the dam was recovered on the operating table until extubation. Heart rate, respiratory rate, pulse oximetry, expelled carbon dioxide, blood pressure, and body temperature were monitored throughout the procedure.
Prior to fetal necropsy and brain harvesting, standard measurements were taken including whole body weight, crown-rump length, right foot length, right hand length, and transtemporal diameter. The chest was bisected, and the left cardiac ventricle was cannulated. The brain and cephalic structures were perfused with ice-cold aerated perfusion solution as previously described (Cuzon Carlson et al., 2011) . The skullcap was removed and the dura reflected using a scalpel and iris or mayo scissors, the brain was hemisected, and the left hemisphere was immersed in ice-cold aerated perfusion solution and transported to the laboratory for electrophysiological experiments. Perfusion of the right hemisphere continued with 4% paraformaldehyde until the brain tissue stiffened (approximately 5 minutes). The right hemisphere was then immersed in 4% Fig. 1 . Experimental timeline. Animals were assigned as either EtOH-drinking or control during an approximately 2-month panel training period. Both groups began schedule-induced polydipsia with water (volume of water equivalent to 1.5 g/kg EtOH, indicated in blue) for a 1-month period. Subsequently, 4% w/v EtOH (red) was introduced for EtOH-drinking animals or an isocaloric maltose dextrin solution (green) for control animals. In approximately 30-day increments, the volume required for each animal to drink was increased from 0.5, to 1.0 to 1.5 g/kg/d. Animals were maintained on 1.5 g/kg/d EtOH (or maltose dextrin) through breeding procedures and the first 60 days of gestation, corresponding to the first trimester. Fetuses were delivered by caesarean section followed by necropsy at 3 end points indicated by Xs. paraformaldehyde overnight and then stored in phosphate-buffered saline for future postmortem MRI and immunohistochemical procedures (Wang and Kroenke, 2015) .
Tissue Preparation and Slice Electrophysiology
Fetal tissue preparation and electrophysiological studies were as previously described for experiments performed in adult rhesus macaques (Cuzon Carlson et al., 2011 . In brief, the left hemisphere of the fetal brain was sectioned coronally (approximately 3 to 5 mm thick) to reveal the dorsal striatum. From the coronal section, a tissue block containing the striatum and overlying white matter was microdissected and immersed in ice-cold sucrose-based cutting solution. Coronal sections (250-lM thin) were obtained with a ceramic blade (Camden Instruments Limited, Lafayette, IN) attached to a Vibroslicer (Leica, Buffalo Grove, IL). Slices were equilibrated for 1 hour in artificial cerebral spinal fluid (aCSF; containing in mM: NaCl, 124; KCl, 4.5; MgCl 2 , 1; NaHCO 3 , 26; NaH 2 PO 4 , 1.2; glucose, 10; CaCl 2 , 2) at a temperature of 33°C, after which they were kept at room temperature until experimental use.
Slices were transferred to a recording chamber fixed to the stage of an upright microscope (Axioskop 2; Zeiss, Thornwood, NY) and continuously perfused with solution maintained at a temperature of 28 to 32°C (Automatic Temperature Controller; Warner Instruments, Hamden, CT). Recording patch pipettes were pulled from borosilicate glass capillaries (1.5 mm outer diameter, 0.86 mm inner diameter; Sutter Instruments Co., Novato, CA) that when filled with a CsCl-based internal solution (contained in mM: CsCl, 150; HEPES, 10; MgCl 2 , 2; Na-GTP, 0.3; Mg-ATP, 3; BAPTA-4K, 0.2) and had a resistance of 4 to 6 MΩ. Slices were constantly perfused with aCSF supplemented with D-(À)2-amino-5-phosphonopentanoic acid (50 lM; Tocris, Ellisville, MO) and 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (5 lM; Tocris) to isolate spontaneous inhibitory postsynaptic currents. Recordings were made using a MultiClamp 700B amplifier (Molecular Devices, Foster City, CA) and whole-cell membrane currents were filtered at 2 kHz, digitized using Clampex v10 (Molecular Devices).
Data Analysis
Comparisons between control and EtOH-drinking subjects were made using unpaired Student's t-tests. A 1-way analysis of variance was used when comparisons were made between more than 2 groups. When repeated measures were necessary, a linear mixedeffects model using the LME package (Pinheiro et al., 2018) in RStudio was used with individual as the subject variable and cohort (3 levels: G85, G110, and G135), time (2 levels: pre-and postpregnancy or first and second 30 days), and their interaction as independent variables. a < 0.05 was set as the threshold for statistical significance. All data are presented as mean AE standard error of the mean, unless otherwise noted.
RESULTS
Alcohol Did Not Alter Menstrual Cycle or Rate of Conception
On average, both control and EtOH-drinking animals had similar menstrual cycle lengths (control: 32 AE 1 days; drinkers: 31 AE 2 days, t (21) = 0.68, p = 0.51). Of successful pregnancies, both control and EtOH-drinking animals had a comparable number of time-mated breeding sessions (controls: 2.4 AE 1.6; drinkers: 2.3 AE 1.4; t (26) = 0.12, p = 0.90). Although there were more EtOH-drinking monkeys that were excluded from the study due to 5 unsuccessful breeding attempts (n = 5, compared to n = 1 control animal excluded in this manner), this was not a statistically significant difference (Fisher's exact probability test, p = 0.20). No spontaneous miscarriages were observed in the viable pregnancies identified by ultrasound at G50. The only notable adverse event was the isolated case of IUGR secondary to placental insufficiency, observed in a control animal (animal 10284; Table 2 ). The age for the control dams (11.7 AE 4.1 years) did not significantly differ from that of EtOH-drinking dams (10.7 AE 3.6 years) at G1 (t (26) = 0.69, p = 0.67).
Pregnancy Alters Fluid Intake that Is Not Specific for EtOH
Each EtOH-drinking animal consumed 1.5 g/kg of EtOH per day; however, the time taken to consume the dose varied by individual and influenced BEC measured at 90 minutes following the initiation of drinking session (Fig. 3) . Despite this variability, a BEC exceeding 80 mg/dl was captured at least once in 13 of the 14 EtOH-drinking dams. Overall, no differences were found in BEC across gestation groups, F(2, 11) = 1.58, p = 0.25, or within the 60 days before and after pregnancy, F(1, 11) = 1.00, p = 0.34. Additionally, while the number of days of EtOH consumption varied prior to pregnancy, there were no differences in lifetime EtOH consumed by dams across the gestational age cohorts (G85: 271.9 AE 33.4 g/kg, G110: 238.2 AE 15.0 g/kg, G135: 259.6 AE 36.3 g/ kg), F(2, 11) = 0.33, p = 0.73.
To illustrate the effect of drinking rate on BEC, Fig. 4 shows the time to complete the EtOH dose for each drinking session for 2 monkeys during the 60 days before and after pregnancy (data are not available for the 3-to 6-day period surrounding day G1 because drinking took place outside of the dams' home cage). Monkey 10309 (Fig. 4A) reliably and rapidly completed the daily 1.5 g/kg dose with a median time to completion of 4.00 AE 0.55 minutes for the 60 days prior to pregnancy and 3.82 AE 0.54 minutes during the first 60 days of pregnancy. In contrast, monkey 10307 (Fig. 4B ) took a considerably longer period of time, 70.50 AE 10.43 minutes over the 60 days prior to pregnancy, and 159.10 AE 48.33 minutes during the first 60 days of pregnancy. As mentioned above, blood collection for BEC occurs 90 minutes after the start of the drinking session, and therefore, the BEC values reflect the amount and pattern of EtOH consumed at 90 minutes. For example, animal 10309 (Fig. 4A inset) completed 1.5 g/kg prior to 90 minutes for all samples taken, leading to consistent BECs over 80 mg/dl. However, animal 10307 (Fig. 4B inset) consumed less than 1.5 g/kg at 90 minutes for 30% of the sessions, leading to lower BECs. Notably, animal 10307 exhibited low intakes at 90 minutes, particularly during the first 60 days of pregnancy when BECs fell below 80 mg/dl.
There was a relationship between gestational day and time to complete the 1.5 g/kg dose. As shown in Fig. 4B , there are multiple occurrences when time to completion exceeded 16 hours during the second month of pregnancy. A similar pattern was observed for several other animals within both the EtOH and control groups. In order to characterize this pattern, the relative latency to consume 1.5 g/kg EtOH or isocaloric dose of maltose dextrin was calculated across 30-day bins. The relative latency is the ratio defined as the median latency over the first (days 1 to 30) and second (days 31 to 60) 30 days of pregnancy divided by the median baseline latency during the 30 days prior to pregnancy for each animal. Figure 5A shows the median relative latencies for all animals, and Fig. 5B shows median relative latencies averaged across control (black) and EtOH-drinking animals (red). A linear mixed-effects model with repeated measures revealed the median relative latency was significantly increased by time (first 30 days: 1.30 AE 0.18, second 30 days: 3.44 AE 0.98), F(1, 28) = 1.74, p = 0.024, but that this was unrelated to EtOH or control gestational group, F (1, 28) = 5.66, p = 0.20, or an interaction between the 2 factors (group*time: F(1, 28) = 2.14, p = 0.15). These data indicate that during the second month after pregnancy, the latency to complete the daily volume of fluid (EtOH or maltose dextrin) significantly increased.
Assessments of Fetal Growth
Ultrasounds were performed on awake animals for pregnancy confirmation at approximately G50 (range: G47 to G67). For a subset of the animals (Table 2) , the BPD, a standard measurement used for fetal biometry, was measured Fig. 3 . BEC 90 minutes after the daily drinking session began for all EtOH-drinking monkeys. Animals are individually colored with mean (SEM) presented on the left and individual BECs across gestational day shown on the right. The lines on the scatterplot indicate pregnancy (G0, black) and the caesarean section and fetal necropsy (red). Data presented include samples collected 60 days before and after pregnancy during 1.5 g/kg/d EtOH induction. (Fig. 6A) . BPD closely tracked the normative growth profile (Tarantal and Hendrickx, 1988) (Fig. 6B , dashed black line) for both EtOH-exposed and control fetuses. Although the EtOH-exposed animals were observed to have a smaller BPD than controls in a previous study for a subset of the G110 cohort (Lo et al., 2017) , EtOH and control fetuses did not differ with regard to difference between observed BPD and the gestational age-corrected normative value in a combined analysis of all fetuses (Fig. 6B) . Fetal brain and placental MRIs were performed on all 28 pregnancies (Fig. 7A,B) . In each case, T 2 -and diffusionweighted brain measurements were of suitable quality to perform retrospective motion correction procedures to reconstruct 3-dimensional (3D) images of each brain (Fogtmann et al., 2014) , as exemplified for 1 animal at each gestational age in Fig. 7A,B . Results from quantitative analyses will be presented in a future report. Placental MRI findings from a subset of the 28 have been reported previously (Lo et al., 2017) .
G85 Cohort
G110 Cohort
G135 Cohort
Immediately following fetal necropsy, ex vivo whole-cell patch clamp electrophysiological measures of intrinsic membrane properties, and excitatory and inhibitory postsynaptic currents were obtained from fetal brain tissue at the 3 gestational end points. Postsynaptic inhibitory current measurements are illustrated in Fig. 7C . These are the first electrophysiological recordings from the fetal rhesus brain and demonstrate mature inhibitory synapses in the caudate nucleus (shown) as well as the putamen and somatosensory cortex (not shown) in fetuses as young as G85. Data from a subset of animals (indicated in Table 2 ) are currently being prepared for a future publication.
DISCUSSION
A primary objective for generating this animal model of FASD was to facilitate the development of neuroimaging biomarkers of abnormal brain development that arise from exposure to EtOH early in gestation and that can be measured in human subjects. Several animal models of FASD have previously utilized MRI to characterize the effect of fetal alcohol exposure on early brain development (Astley et al., 1995; Godin et al., 2010; Leigland et al., 2013b; O'Leary-Moore et al., 2010; Parnell et al., 2009 Parnell et al., , 2013 Parnell et al., , 2014 Tang et al., 2018) and see O'Leary-Moore and colleagues (2010) and Wang and Kroenke (2015) for review. However, these studies primarily focused on rodents, which are born at earlier stages of CNS development than humans. Therefore, the MRI procedures performed during the early postnatal period, or on ex vivo brain tissue, are not easily translatable to human subjects. One notable exception acquired MRI measurements in macaques, however not until they were 2.4 to 4.1 years of age (Astley et al., 1995) , which is the human equivalent to early to late adolescence.
A similarity between humans and NHPs is that NHPs will voluntarily drink alcohol over long periods of time in a The BEC values for the monkey 10309 consistently reflect consumption of the full 1.5 g/kg of EtOH, whereas for monkey 10307, drinking took place over an interval longer than 90 minutes, and as a consequence the 90-minute BEC was lower. manner that closely resembles human drinking (Grant et al., 2008; Vivian et al., 2001) . Previously, NHP models of FASD have first established pregnancies and then used methods of EtOH administration, including controlled amounts of EtOH at weekly intervals via intragastric gavage (Astley et al., 1995; Clarren et al., 1987) . A potential confound associated with this method is that it is nonvoluntary and therefore induces stress, which can negatively affect fetal development (Schneider et al., 2002) . Another NHP model of FASD relied on voluntary drinking for alcohol administration (Burke et al., 2009 ), but in this case, the alcohol dose along with other biological variables such as age, timing in pregnancy, and variables relevant to nutrition was not tightly controlled. The NHP model of FASD developed here provides self-paced drinking with precisely controlled measures of alcohol intake and resultant BEC during a defined period of early gestation.
In previous studies of fetal alcohol exposure in rhesus macaques, the severity of outcomes on pregnancy and fetal development depended on the dose of EtOH administered. The occurrence of adverse pregnancy outcomes such as miscarriage was observed in animals that were gavaged weekly with EtOH doses of 1.8 g/kg or greater (Clarren and Astley, 1992; Clarren et al., 1987) . The anatomical consequences of EtOH exposure worsened with EtOH dose (Bonthius et al., 1996) . Corresponding cognitive and behavioral deficits were also observed in these animals (Clarren and Astley, 1992; Clarren et al., 1988) . In the above studies, the timing with respect to gestation, as well as the EtOH dose, influenced the severity of EtOH-related insults, with early exposure having a larger impact on fetal development than later exposure. For example, doses of 2.5 g/kg or higher, introduced prior to 5 weeks gestation, consistently produced nonviable pregnancies, whereas viable pregnancies for doses up to 4.1 g/kg Biparietal diameter A B Fig. 6 . Representative ultrasound BPD measurement for a G48 fetus (A). Images were obtained from an awake dam trained to sit calmly for the procedure. (B) The BPD measurements for 13 fetuses fit the normative growth curve for rhesus macaques previously published by Tarantal and Hendrickx (1988) (dashed black line). EtOH-na€ ıve controls shown in black and EtOH-exposed in red.
were possible beginning after 5 weeks gestation (Clarren and Astley, 1992) . It has also been demonstrated that early gestation is associated with greater sensitivity to long-term consequences on cerebral cortical and white matter structure (Miller, 2007) . In the weekly gavage paradigm, it was repeatedly observed that dams that experienced peak BEC values of 140 mg/dl and higher were at greater risk of a poor fetal developmental outcome (Clarren and Astley, 1992; Clarren et al., 1988) . There are several differences between our study and the experimental conditions in which the 140 mg/dl BEC threshold was observed, such as the daily (as opposed to weekly) exposure in our study. However, we note that a BEC of 140 mg/dl on at least 1 occasion during pregnancy was documented in multiple dams (4 of 14; Fig. 3) .
In general, inducing monkeys to drink 1.5 g/kg EtOH in this study did not influence the establishment or maintenance of pregnancy, but rather, pregnancy influenced drinking patterns. Specifically, both EtOH and maltose dextrin drinking animals exhibited increased relative latency to finish the 1.5 g/kg EtOH (or caloric equivalent) dose. This finding resembles previous observations that pregnant rhesus macaques have an increased likelihood for rejecting food in the second month of pregnancy, compared to earlier and later stages of gestation (Czaja, 1975) . Lower food intake was attributed to changes in circulating ovarian hormone levels and specifically associated with increasing E2 and decreasing P4 during the second month of gestation. This pattern is consistent with relatively lower incidence of food rejection in the luteal phase, characterized by high P4 and low E2 levels, of the rhesus menstrual cycle (Czaja, 1975) . A similar pattern in voluntary EtOH self-administration in female rhesus macaques is observed, in which for regularly menstruating animals, EtOH intake is higher in the luteal phase when P4 levels are high (Dozier BL, Stull CA, Baker EJ, Ford MM, Jensen JP, Finn DA, Grant KA, unpublished observations). Thus, for pregnant animals, high incidence of food rejection coincides with less rapid drinking, and in nonpregnant animals, low incidence of food rejection coincides with increased EtOH drinking. Although further investigation is needed to more firmly link drinking behavior to P4 levels in pregnant rhesus macaques, this subtle aspect of EtOH self-administration observed in our animal model may also influence the typical pattern of EtOH exposure in women early in pregnancy prior to pregnancy knowledge.
Three important variables in animal models of FASD are the timing of EtOH exposure during gestation, the EtOH dose, and the route of administration. The gestational timing selected for this model (the first 60 days of pregnancy) was motivated, as described above, by the desire to model human drinking prior to pregnancy awareness. The daily 1.5 g/kg EtOH dose was chosen based on previous reports of this dose having a significant effect on offspring development (Clarren and Astley, 1992) . The route of administration, relying on self-motivated drinking, has positive attributes of inducing minimal stress and facilitating analysis of latencies to complete drinking throughout the first 60 days of pregnancy, but it is not compatible with ensuring equal peak BEC values for all animals. Animals that complete their drinking procedures faster achieve a higher peak BEC than animals that drink more slowly (Fig. 4) . In future studies to examine the effect of EtOH exposure on fetal brain development, analyses will be performed to determine whether outcome measures scale with BEC at 90 minutes following the initiation of daily drinking.
An additional limitation of studies involving NHP subjects is that they are costly to maintain compared to other animal model species, and it is therefore not possible to obtain data from large group sizes. This study was able to generate 14 EtOH-exposed and 14 control fetuses, but these were split across 3 time points for each group, and final gestation age and treatment groups consisted of 4 to 5 animals. Anomalous cases are present in the G135 control and EtOHexposed groups. In the former, a case of IUGR secondary to placental insufficiency was observed (Lo et al., 2018) . In the latter, an animal was exposed to EtOH over a lengthier gestational age range than intended (108 days of drinking; Table 2 ). Due to the value of each of these animals, the results obtained from them will be included in future reports, and the details of these deviations from the planned experiments documented here will provide important reference information.
It was possible to collect in utero MRI data on all fetuses generated in this study, at 3 time points throughout the second and third trimesters (G85, G110, and G135). Due to its noninvasive nature, MRI is a method that could, in principle, be used to study human fetuses that have been exposed to alcohol in utero to address the challenge of early detection. Studies of humans affected by FASD have identified many anatomical and functional brain abnormalities associated in childhood through adult-aged individuals (Norman et al., 2009) . However, to date in utero, postnatal or childhood MRI studies of human subjects have not been referenced to details of alcohol drinking, such as dose, frequency, and timing of use. Further, the gestational stage in which MRI possesses the greatest sensitivity to impaired CNS development is not currently known. The model described in this study will be used to evaluate these questions and extend the in utero MRI imaging to functional consequences of anatomical abnormalities. Shown in Fig. 7 are the first electrophysiological investigations of excitatory and inhibitory synapses in the fetal striatum and cortex of rhesus macaques. Thus, this macaque model also provides the unique opportunity to complement the in utero MRI measures with ex vivo functional measures of synaptic function. Importantly, the ex vivo electrophysiology can be adapted to incorporate immunohistochemistry and genomic approaches that further characterize the regions, populations, and specific cellular adaptations that result from early-gestation EtOH exposure.
While the current focus is on investigating fetal brain development, the opportunity to apply molecular and synaptic underpinnings of in vivo imaging and ultimately behavioral outcomes following birth represents a rich area for understanding the trajectory of FASD. We anticipate that through antenatal and postnatal investigations, it will be possible to implement and evaluate potential therapeutic interventions.
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